Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 9 - Medicinal preparations characterised by special physical form
Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044)
03/2005
03/08/2005US6863901 Pharmaceutical composition for compressed annular tablet with molded triturate tablet for both intraoral and oral administration
03/08/2005US6863899 Composite shaped bodies and methods for their production and use
03/08/2005US6863898 Method and composition for treating hairy hoof warts
03/08/2005US6863891 Oligopeptide lyophilisate, their preparation and use
03/08/2005US6863865 Sterilization of pharmaceuticals
03/08/2005US6863211 Omega-hydrofluoroalkyl ethers, precursor carboxylic acids and derivatives thereof, and their preparation and application
03/08/2005US6862890 Process for production of nanoparticles and microparticles by spray freezing into liquid
03/08/2005CA2446562C Pharmaceutical formulation of fluticasone propionate
03/08/2005CA2351848C Method for increasing pet activity
03/08/2005CA2349672C Method for preparing capsules consisting of a liquid active material core enclosed in a mineral coating
03/08/2005CA2318125C Methods and kits for treating vulvovaginal candidiasis with miconazole nitrate
03/08/2005CA2277277C Expandable gastro-retentive therapeutic system with controlled active substance release in the gastro-intestinal tract
03/08/2005CA2239952C Surface-stabilised pharmaceutical preparation for application on the skin
03/08/2005CA2230723C Non-ionic amphiphilic lipid and aminosilicone nanoemulsion and its uses
03/08/2005CA2190134C Continuous method of grinding pharmaceutical substances
03/03/2005WO2005019286A1 Novel coating composition
03/03/2005WO2005019061A1 Micronutrient supplement dispensing package
03/03/2005WO2005018708A2 Magnetic circumferentially coupled implantable pump
03/03/2005WO2005018702A2 Active agent delivery systems including a miscible polymer blend, medical devices, and methods
03/03/2005WO2005018697A2 Active agent delivery systems, including a single layer of a miscible polymer blend, medical devices, and methods
03/03/2005WO2005018687A2 Particle-size reduction apparatus, and use thereof
03/03/2005WO2005018685A2 System and apparatus for remote activation of implantable medical devices
03/03/2005WO2005018678A1 Additives for tablet
03/03/2005WO2005018651A1 Pharmaceutical formulation comprising lanthanum compounds
03/03/2005WO2005018646A1 Ophthalmic composition
03/03/2005WO2005018623A2 Parenteral and oral formulations of benzimidazoles
03/03/2005WO2005018619A1 Medicament preparations for transdermal application containing active ingredient combinations for treating parkinson's disease
03/03/2005WO2005018618A1 Formulation of stable for moisture absorption and quickly dissolved tablet containing cefuroxime axetil and it's manufacturing process
03/03/2005WO2005018617A1 Fast dissolving tablet
03/03/2005WO2005018616A1 Method for deterring abuse of opioids by combination with non-release formulation of emetic
03/03/2005WO2005018615A1 Tablet containing 3-[(2-{[4-(hexyloxycarbonylamino-imino-methyl)-phenylamino]- methyl}-1-methyl-1h-benzimidazolo-5-carbonyl)-pyridino-2-yl- amino]-ethyl propionate or the salts thereof
03/03/2005WO2005018614A1 Powder formulation comprising the cgrp antagonist 1- (n2-(3,5-dibromo-n-(4-(3,4-dihydro-2(1h)-oxoquinazolin-3-yl)- 1-piperidinyl)carbonyl)-d-tyrosyl)-l-lysyl)-4-(4-pyridinyl)-piperazine
03/03/2005WO2005018613A1 Pellets for the oral application of pharmaceutical active substances
03/03/2005WO2005018611A1 Particle size reduction of bioactive compounds
03/03/2005WO2005018610A1 In vivo targeting of dendritic cells
03/03/2005WO2005018609A1 Microparticles comprising the cgrp antagonist 1-[n2-[3,5-dibromo-n-[[4-(3,4-dihydro-2(1h)-oxoquinazolin-3-yl)-1-piperidinyl]carbonyl]-d-tyrosyl]-l-lysyl]-4-(4-pyridinyl)-piperazine method for production and use thereof as inhalation powder
03/03/2005WO2005018608A1 Drug delivery system for sub-tenon’s capsule administration of fine grains
03/03/2005WO2005018607A1 Medicinal preparation having improved dissolution properties
03/03/2005WO2005018606A1 Medical devices comprising spray dried microparticles
03/03/2005WO2005018605A2 Novel formulation of ropinirole
03/03/2005WO2005018604A2 Novel inhalation powder comprising the cgrp antagonist 1-[n2-[3,5-dibromo-n-[[4-(3,4-dihydro-2(1h)-oxoquinazolin-3-yl)-1-piperidinyl]carbonyl]-d-tyrosyl]-l-lysyl]-4-(4-pyridinyl)-piperazine
03/03/2005WO2005018603A2 Spray-dried amorphous bibn 4096 method for production and use thereof as inhalant
03/03/2005WO2005018602A2 Method for the production of effervescent granules in a vacuum
03/03/2005WO2005018601A1 Aqueous pharmaceutical solution containing oxymetazoline and/or xylometazoline
03/03/2005WO2005018600A2 Method of treating a patient suffering from a solid tumour
03/03/2005WO2005018585A1 Pharmaceutical and cosmetic formulations for treating fingernails
03/03/2005WO2005018583A1 Composition for treatment of tinea pedis and method of use
03/03/2005WO2005018582A2 Compositions containing topical active agents and pentylene glycol
03/03/2005WO2005018566A2 Topical delivery system containing colloidal crystalline arrays
03/03/2005WO2005018565A2 Compositions for delivering 5-ht agonists across the oral mucosa and methods of use thereof
03/03/2005WO2005018533A2 Eletrostatically charged nasal application product with increased strength
03/03/2005WO2005018530A2 Penetrating pharmaceutical foam
03/03/2005WO2005018517A1 Transdermal patch incorporating active agent migration barrier layer
03/03/2005WO2005018505A1 Thermal treatment to improve intraocular lens inserter lubricity
03/03/2005WO2005009420A3 Pharmaceutical compositions of short-acting sedative hypnotic agent
03/03/2005WO2005007142A3 Liquid compositions comprising formoterol
03/03/2005WO2004113422A3 Drug delivery device comprising an active compound and method for releasing an active compound from a drug delivery device
03/03/2005WO2004112747A3 Specific delivery of drugs to the brain
03/03/2005WO2004110151A8 Treatment of cancer with active vitamin d compounds in combination with radiotherapeutic agents and treatments
03/03/2005WO2004098570B1 Nanoparticulate bioactive agents
03/03/2005WO2004098565A3 Implantable controlled release bioactive agent delivery device
03/03/2005WO2004096189A3 The dispersible alendronate microparticle formulation
03/03/2005WO2004094370A3 Antibacterial pyrazole carboxylic acid hydrazides
03/03/2005WO2004093819A3 Tamper resistant dosage form comprising co-extruded, adverse agent particles and process of making same
03/03/2005WO2004091536A3 An albuterol and ipratropium inhalation solution, system, kit and method for relieving symptoms of chronic obstructive pulmonary disease
03/03/2005WO2004091530A3 Homogeneous, thermoreversible gel film containing kappa-2 carrageenan and soft capsules made therefrom
03/03/2005WO2004091521A3 Methods and compositions for administration of trpv1 agonists
03/03/2005WO2004088029B1 Disposable, paper-based hospital and operating theater products
03/03/2005WO2004087100A3 Cladribine formulations for improved oral and transmucosal delivery
03/03/2005WO2004084859A3 Nasal calcitonin formulations containing chlorobutanol
03/03/2005WO2004038460A3 Aqueous ophthalmic spray and method for delivery
03/03/2005WO2004035004A3 Effervescent compositions comprising bisphosphonates and methods related thereto
03/03/2005WO2004028477A3 Methods for treatment and/or prevention of retinal disease
03/03/2005WO2004005306A8 Metallic object with a nucleic acid coating and derivatives thereof and method for producing said object
03/03/2005US20050050191 Storage network and method for storage network device mapping
03/03/2005US20050049659 Articles for therapeutic paraffin treatment and methods of use
03/03/2005US20050049578 Implantable ocular pump to reduce intraocular pressure
03/03/2005US20050049571 Device and method for delivering or withdrawing a substance through the skin
03/03/2005US20050049466 Optical sampling interface system for in vivo measurement of tissue
03/03/2005US20050049365 Method for preparing a two-phase water-absorbent bioadhesive composition
03/03/2005US20050049359 Amelioration of ischemic damage using synthetic oxygen carriers
03/03/2005US20050049314 Buffering; near neutral to slightly alkaline pH
03/03/2005US20050049311 Medicinal products comprising prostaglandin compositions and methods of packaging such compositions
03/03/2005US20050049306 Non-halogenated naphthol compounds, antimicrobial compositions containing the same, and methods of using the same
03/03/2005US20050049291 Process for the preparation of pharmaceutical compositions for topical delivery of cyclooxygenase-2-enzyme inhibitors
03/03/2005US20050049279 Sustained release daily dosage form comprising D-threo methylphenidate; substantially free of L-threo and erythro optical isomers; minimizing side effects, increasing efficacy
03/03/2005US20050049233 Transdermal administering of testosterone
03/03/2005US20050049232 Preventing hair loss and/or stimulating growth; active ingredient combined with lipophilic and hydrophilic two phase system; creates semipermeable membrane in skin holding medication in appropriate area; reduced irritation and systemic effects
03/03/2005US20050049223 Basic drug compositions with enhanced bioavailability
03/03/2005US20050049216 Immunostimulatory nucleic acid molecules
03/03/2005US20050049215 contain unmethylated cytosine-guanine (CpG) dinucleotides; stimulating interferon-alpha to treat viral infections; oligonucleotide linked to a biodegradable delivery complex
03/03/2005US20050049210 Methods for the controlled delivery of pharmacologically active compounds
03/03/2005US20050049209 Pharmaceutical compositions for delivering macrolides
03/03/2005US20050049196 Indirect delivery of growth factors into the central nervous system
03/03/2005US20050048650 Heterofunctional copolymers of glycerol and polyethylene glycol, their conjugates and compositions
03/03/2005US20050048144 Herb extract-based cosmeceutical cream for controlling the blood sugar level of diabetes and methods for making it
03/03/2005US20050048127 Small spherical particles of low molecular weight organic molecules and methods of preparation and use thereof
03/03/2005US20050048126 Formulation to render an antimicrobial drug potent against organisms normally considered to be resistant to the drug
03/03/2005US20050048123 Liquid sustained release ; in situ injecting of water insoluble gel in polyoxyethylene glycol solvent
03/03/2005US20050048122 Method for stabalizing timolol concentration
1 ... 1852 1853 1854 1855 1856 1857 1858 1859 1860 1861 1862 1863 1864 1865 1866 1867 1868 1869 1870 1871 1872 ... 2991